IgM is the fi rst Ig isotype to appear during phylogeny, ontogeny, and the immune response, and has been suggested as a fi rst line of host defense to pathogens. Serum levels of IgM in mice raised under germ-free conditions are similar to those of mice maintained under conventional housing conditions ( Haury et al., 1997 ) . Thus, production of preimmune "natural" IgM antibody, primarily by CD5 + B-1 cells, is likely to be regulated by mechanisms unrelated to exogenous antigen specifi city. In contrast, antigeninduced IgM production is mainly derived from conventional B-2 cells. The importance of both natural and induced IgM antibodies in immune responses has been established through recent studies of a mutant mouse strain in which B cells expressing surface IgM and IgD could switch and secrete IgG and IgA, but not IgM, antibodies ( Boes et al., 1998a ; Ehrenstein et al., 1998 ) . These mutant mice had impaired control of viral and bacterial infections because of ineffi cient induction of protective IgG antibody responses ( Boes et al., 1998b ; Ochsenbein et al., 1999 ; Baumgarth et al., 2000 ) . Thus, these fi ndings indicate that IgM antibody can profoundly infl uence immune responses and suggest that some of these eff ects are mediated by binding to eff ector molecules such as Fc receptor (FcR) and complement via its carboxylconstant regions.
Several FcRs, namely FcR for IgG (Fc ␥ RI/ CD64, Fc ␥ RII/CD32, and Fc ␥ RIII/CD16), IgE (Fc RI), and IgA (Fc ␣ R/CD89), have been characterized at both the protein and nucleic acid levels .
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Identity of the elusive IgM Fc receptor (Fc R) in humans
originally designated as TOSO, after a Japanese liquor drunk on New Year's day to celebrate long life and eternal youth ( Hitoshi et al., 1998 ) . Interestingly, however, the apoptosis in this functional assay was induced by ligation of Fas with a mouse mAb of IgM isotype (CH11). This immediately raised the possibility that the CH11 mAb bound to the Fas via its Fab portion and to the FAIM3/TOSO via its Fc portion, thereby bringing them in close physical proximity in a process reminiscent of that described in Fc ␥ RIIb-mediated inhibition of BCR signaling by intact IgG anti-antibodies ( Tony and Schimpl, 1980 ; Ravetch and Nimmerjahn, 2008 ) .
In contrast, FcR for IgM (Fc R) has defi ed genetic identification, although the existence of Fc R on B, T, NK, and phagocytic cells has been suggested for >30 yr with variable and confl icting results ( Basten et al., 1972 ; Moretta et al., 1975 ; Lamon et al., 1976 ; Ferrarini et al., 1977 ; Moretta et al., 1977 ; Pichler and Knapp, 1977 ; Santana, 1977 ; Haegert, 1979 ; Reinherz et al., 1980 ; Uher et al., 1981 ; Sanders et al., 1987 ; Mathur et al., 1988a ; Mathur et al., 1988b ; Ohno et al., 1990 ; Nakamura et al., 1993 ; Pricop et al., 1993 ; Rabinowich et al., 1996 ) . In addition to the aforementioned classical FcRs, several other receptors expressed on unique cell types also bind Ig molecules: (a) neonatal FcR for IgG (FcRn) on intestinal epithelium, placenta, and endothelium ( Roopenian and Akilesh, 2007 ) ; ( b) low affi nity Fc R (Fc RII/CD23) on B cells and macrophages ( Conrad, 1990 ) ; (c) polymeric Ig receptor (pIgR) on mucosal epithelium ( Kaetzel, 2005 ) ; and (d) FcR for IgA and IgM (Fc ␣ / R; Shibuya et al., 2000 ) on follicular dendritic cells ( Kikuno et al., 2007 ) . Although the latter two receptors bind polymeric IgA and IgM, their biochemical features and cellular distribution are distinct from those of the Fc R that we have previously characterized on B and T cells in humans ( Sanders et al., 1987 ; Ohno et al., 1990 ; Nakamura et al., 1993 ) . In this paper, we have identifi ed a cDNA encoding a bona fi de Fc R that is defi ned as transmembrane protein of ‫ف‬ 60 kD expressed predominantly on B and T lymphocytes.
RESULTS

Molecular cloning of the Fc R
Our previous cellular and biochemical studies provided strong evidence for the existence of an Fc R that is expressed constitutively on chronic lymphocytic leukemia (CLL) B cells and inducibly on pre-B cell lines ( Sanders et al., 1987 ; Ohno et al., 1990 ) . To identify the gene encoding the putative Fc R, two diff erent cDNA libraries from CLL B cells and a PMA-activated 697 pre-B cell line were constructed in a retroviral expression vector and then introduced into mouse T cell line BW5147. Transduced cells exhibiting IgM binding were enriched by FACS and subcloned. Many of the single cell-derived subclones from both cDNA libraries bound IgM ( Fig. 1 A ) . RT-PCR analysis revealed that a DNA fragment of ‫ف‬ 2 kb was specifi cally amplifi ed only from IgMbinding subclones ( Fig. 1 B ) , and their nucleotide sequence analyses defi ned an identical 1,173-bp open reading frame (CLL-and PMA-activated 697 pre-B cell-derived Fc R cDNA available from GenBank/EMBL/DDBJ under accession nos. GQ160900 and GQ160901 , respectively; Fig. S1 ). Basic local alignment search technique database analysis revealed that the isolated Fc R cDNA was identical to that of the previously described human Fas apoptotic inhibitory molecule 3 (FAIM3; available from GenBank/EMBL/DDBJ under accession no. NM_005449 ), except for one nucleotide diff erence at a position reported as a synonymous single nucleotide polymorphism. FAIM3 was identifi ed in a similar retroviral cDNA library-based functional assay as a potent inhibitor of Fas/CD95-induced apoptotic signaling and was or IgMnonbinding (lanes 2 and 6) subclones from CLL-derived (lanes 2-5) and PMA-activated 697 pre-B cell-derived (lanes 6-9) cDNA libraries were subjected to RT-PCR as described in Materials and methods. Amplifi ed products were electrophoresed in 0.7% agarose and stained with ethidium bromide. Lane 10 is a PCR control without a fi rst-strand cDNA template. Hin dIII-digested DNA was used as a size marker. The experiments were performed once for A and twice for B.
The FAIM3/TOSO gene encodes a bona fi de Fc R To reconcile the confl icting functions of FAIM3/TOSO and our functionally defi ned Fc R, an ‫ف‬ 1.2-kb cDNA containing the protein coding region of FAIM3/TOSO/Fc R was PCR amplifi ed from PMA-activated 697 pre-B cells, subcloned along with a GFP cDNA into the bicistronic retroviral vector and then transduced into BW5147 T cells. The resultant GFP + transductants clearly exhibited IgM binding ( Fig. S2 ) , thereby confi rming that FAIM3/TOSO is an IgM receptor. The Fc R cDNA is predicted to encode a 390-aa type I membrane protein (17-aa signal peptide, 236-aa extracellular region, 19-aa transmembrane segment, and 118-aa cytoplasmic tail). The N-terminal half of the extracellular region contains a single V-set Ig-like domain with homology to both the pIgR and Fc ␣ /μR (see next section), but the remaining extracellular region has no identifi able domain features ( Fig. S3 ). There are no N-linked glycosylation motifs in the extracellular region, consistent with our previous biochemical characterization of the Fc R ( Ohno et al., 1990 ) . The mature core peptide is predicted to have an M r of ‫ف‬ 41 kD and an isoelectric point (pI) of ‫ف‬ 9.9.
A quantitative inhibition immunofl uorescence assay with various Ig isotypes and IgM fragments as inhibitors revealed that IgM and its Fc 5 μ fragments consisting mostly of C 3/ C 4 domains inhibited the binding of a biotin-labeled human IgM to Fc R + BW5147 T cells in a dose-dependent manner, whereas the Fabμ fragments and other human Ig isotypes (IgG 1-4 , IgA 1,2 , IgD, and IgE) did not, thereby confi rming the Fc specifi city of the Fc R ( Fig. 2 A ) . Fig. 2 B shows a representative inhibition profi le for IgM binding with an eightfold excess of inhibitors. The inability of Fc R to bind polymeric IgA clearly indicates that Fc R is distinct from pIgR and Fc ␣ /μR, both of which are shown to bind IgM and polymeric IgA. Moreover, the lack of binding to aggregated IgG further confi rms the unique IgM isotype specifi city of this receptor. Interestingly, mouse IgM bound better to the human Fc R than human IgM, and essentially identical Fc R binding was observed with IgM and IgM ligands irrespective of the presence of Ca 2+ /Mg 2+ . The affi nity of IgM/Fc R binding was estimated by Scatchard plot analysis using 125 I-labeled human IgM and Fc R + BW5147 T cells. Assuming a 1:1 stoichiometry of pentameric IgM ligand to Fc R, this analysis revealed a strikingly high binding affi nity of 10.8 ± 9.2 nM (mean ± SD from four experiments with two diff erent human IgM myeloma proteins). Pretreatment of Fc R + cells with neuraminidase slightly enhanced IgM binding, suggesting a role of sialic acid in this interaction, as reported previously by others ceptors. Arg63 and Asp86 are also completely conserved, but Trp37 is found only in the pIgR and Fc ␣ / R. Several other residues (Gly6, Tyr24, Val29, Arg31, Lys35, Tyr55, and Leu101) are also conserved in pIgR and Fc ␣ / R but not in Fc R. A major diff erence between Fc R and the other two receptors is in the CDR1 region. The CDR1 of the pIgR from six diff erent species consists of 9 aa (Pro25 to Thr33), and this is also the case in the Fc ␣ / R from two diff erent species. In contrast, the corresponding region of the Fc R from seven diff erent species consists of 5 aa and has a noncharged residue (Met, Leu, or Thr) at the position corresponding to Arg31, which has been shown to be solvent exposed and possibly to interact directly with polymeric IgA in the human pIgR ( Hamburger et al., 2004 ) . These results suggest a structural basis for the distinct mode of IgM interactions with Fc R versus pIgR and Fc ␣ / R.
Conserved Ser and Tyr residues in the cytoplasmic tail of Fc R A charged His residue is adjacent to or within the putative 19-aa transmembrane segment of Fc R from all species examined except for the bovine ( Fig. 4 ) . The 118-aa cytoplasmic ( Pricop et al., 1993 ) . Higher concentrations (>100-fold) were required for binding of IgM monomers to the Fc R + cells than IgM pentamers, indicating the importance of IgM ligand confi guration ( Fig. 2 C ) ( Hitoshi et al., 1998 ) . A comparison of the protein sequence of the Ig-binding domains of Fc R, pIgR, and Fc ␣ / R to the pIgR structural data reported by Hamburger et al. ( 2004 ) provided some potential insight into ligand specifi city ( Fig. 3 ) . In addition to a disulfi de bond between Cys22 and Cys92 linking the two ␤ sheets (B and F strands), a second disulfi de bond between Cys38 and Cys46 linking the C and C Ј strands is also conserved in all three re- Figure 3 . aa sequence alignment of IgM-binding receptors. The Ig-binding domains of pIgR, Fc ␣ / R, and Fc R from several species were aligned using the CLUSTAL W multiple alignment program ( Thompson et al., 1994 ) . aa identity is indicated by dots and gaps are indicated by dashes. Residues conserved in all three receptors and in pIgR and Fc ␣ / R are highlighted in yellow and red, respectively. The numbers indicate the aa position from the N terminus of the Ig-binding domain of human pIgR. These sequences are available from GenBank/EMBL/DDBJ under the following accession nos.: pIgR of human (hu; P01833 ), rabbit (rb; P01832 ), mouse (mo; O70570 ), rat (rt; P15083 ), bovine (bo; P81265 ), and chicken (ch; AAP69798 ); Fc ␣ / R of human ( AAL51154 ) and mouse ( NP_659209 ); and Fc R of human ( NP_005440 ), chimpanzee (cm; XP_001165341 ), monkey (mn; XP_001084243 ), bovine ( XP_588921 ), dog (do; XP_547385 ), mouse ( NP_081252 ), and rat ( Q5M871 ).
phosphoserine of PKC substrates. Phosphorylation of both serine and tyrosine residues was clearly demonstrated in pervanadate-treated cells but not in untreated cells ( Fig. 5 A ) . Interestingly, the serine-phosphorylated Fc R migrated at ‫ف‬ 52 kD, whereas most of the tyrosine-phosphorylated Fc Rs migrated at ‫ف‬ 60 kD and, to a lesser extent, at ‫ف‬ 52 kD. When these membranes were reprobed with anti-Fc R mAb specifi c for its extracellular epitope, we found that in resting cells Fc R was present as a major band of ‫ف‬ 60 kD, which is consistent with the M r of the cell-surface Fc R (see Fig. 7 ), along with a minor band of ‫ف‬ 45 kD, but in pervanadate-treated cells the Fc R was resolved as a major band of ‫ف‬ 52 kD together with multiple minor species of various sizes. When Fc R was cross-linked with preformed immune complexes consisting of IgM and F(ab Ј ) 2 fragments of anti-mAb, phosphorylation of both serine and tyrosine residues of the ‫ف‬ 52 kD Fc R was also demonstrated as early as 3 min after ligation. The serine phosphorylation became more prominent at 30 min after ligation, whereas tyrosine phosphorylation was diminished by that time point ( Fig. 5 B ) . In contrast to the eff ects seen with pervanadate treatment, tyrosine-phosphorylated ‫ف‬ 60-kD Fc R was not observed in the lysates of receptor-ligated cells. Reprobing of these membranes with anti-Fc R mAb revealed the presence of both ‫ف‬ 60-and ‫ف‬ 52-kD Fc R proteins as well as minor, but discrete, bands of ‫ف‬ 45 and ‫ف‬ 63 kD. Collectively, these fi ndings suggest that the conserved serine and tyrosine residues seen in the cytoplasmic tail of Fc R are indeed potentially phosphorylated upon receptor ligation and that the phosphorylated Fc R protein migrates diff erently on SDS-PAGE compared with its unphosphorylated form.
tail is composed of a basic aa-rich region, a Pro-rich region, two conserved Cys residues, and an acidic aa-rich region in all seven diff erent Fc Rs. Of the Ser residues, fi ve are completely conserved and an additional four are highly conserved among these Fc Rs, and some of them are potential sites for protein kinase C (PKC) phosphorylation (R/K 1-3 -X 0-2 -S/ T-X 0-2 -R/K 1-3 or R/K-X-S-Z-R/K, where Z represents a hydrophobic aa residue) or casein kinase 2 phosphorylation (S/T-X 2 -D/E). Three Tyr residues are also completely conserved among these Fc Rs, but none of them (
However, if phosphorylated, the most carboxyl tyrosine is a potential binding site (pY-X-N-X) for the Src homology 2 domains of growth factor receptor-bound protein 2 and growth factor receptor-bound protein 2-related adaptor protein, as observed in transmembrane adaptor proteins, including linker for activation of T cells and non-T cell activation linker ( Horejsí et al., 2004 ) . These fi ndings indicate a quite distinct feature of the Fc R cytoplasmic tail compared with other FcRs, in which the Ig ligand binding chains are usually devoid of conserved Tyr residues except for Fc ␥ RIIA and Fc ␥ RIIB.
To determine whether these conserved Ser and Tyr residues are phosphorylated upon stimulation, Fc R + BW5147 T cells were treated with a tyrosine phosphatase inhibitor, pervanadate, or with preformed IgM immune complexes to crosslink Fc R. The Fc R was immunoprecipitated from the lysates of resting or activated cells and analyzed by immunoblotting with antibodies specifi c for phosphotyrosine or the Figure 4 . aa sequence alignment of the transmembrane and cytoplasmic regions of Fc Rs. aa sequences of the transmembrane segments and cytoplasmic tails of Fc R from seven different species are aligned. aa identity is indicated by dots, and a deletion is indicated by dashes. The predicted transmembrane region is highlighted in red. Conserved serine and tyrosine residues are also highlighted in blue and yellow, respectively. The numbers indicate the aa position from the fi rst Met residue of human Fc R. The GenBank/EMBL/DDBJ accession nos. for these Fc Rs are the same as those in Fig. 3 . Chimp, chimpanzee.
tor with the IgG 3 antibody induced apoptosis in all three cell types, including the Fc R + GFP + cells. Notably, ligation of Fc R and Fas with the corresponding mAbs either in the absence (i.e., separate ligation of each receptor) or presence of a common secondary reagent (i.e., coligation of both receptors) had no demonstrable eff ects on the IgG 3 anti-Fas mAbinduced apoptosis of Fc R + GFP + cells. Essentially identical results using IgM versus IgG 3 anti-Fas mAb were also obtained with EBV-transformed B cell lines expressing both endogenous Fc R and Fas on their cell surface (unpublished data). Collectively, these fi ndings indicate that Fc R has no intrinsic activity to inhibit Fas-mediated apoptosis, but they raise the interesting possibility that IgM anti-Fas autoantibody, if present in individuals with autoimmune disorders, could interrupt Fas-mediated signaling via Fc R in vivo.
To determine if Fc R could also aff ect apoptosis mediated through the BCR, the same retroviral constructs as used for Jurkat cells were transduced into a mouse immature B cell line, WEHI231, and a human germinal center B cell line, Ramos, both of which are negative for Fc R expression and are known to undergo apoptosis after BCR cross-linking. However, unlike the Jurkat T cell line, no cell lines of either type that stably expressed both Fc R and GFP were obtained after multiple attempts in diff erent laboratories (unpublished data), whereas control GFP + cell lines were easily established. Even after enriching GFP hi cells by FACS or by antibiotic selection, the established cell lines were found to express low levels of GFP and no cell-surface expression of Fc R. Flow cytometric analysis of these B cell lines shortly Fc R per se has no antiapoptotic activity To determine whether Fc R inhibits Fas-mediated apoptosis as originally described for FAIM3/TOSO ( Hitoshi et al., 1998 ) , retroviral constructs containing both Fc R and GFP cDNAs or only the GFP cDNA were transduced into the apoptosis-prone Jurkat human T cell line. Cells expressing comparable levels of GFP were enriched from each transductant by FACS, and the Fc R/GFP transductant was found to express relatively high levels of cell-surface Fc R as determined by both receptor-specifi c mAbs (see next section) and IgM ligand binding ( Fig. 6 A ) . The resultant Fc R + GFP + or GFP + Jurkat cells and nontransduced Jurkat cells as an additional control were then subjected to apoptosis assays using agonistic anti-Fas mAbs of the IgM or IgG 3 isotype. Cross-linkage of Fas with the IgM antibody induced robust early (annexin V + /7-aminoactinomycin D [7-AAD] Ϫ ) and late (annexin V + /7-AAD + ) apoptotic cells as well as dead cells (annexin V Ϫ /7-AAD + ) in the nontransduced Jurkat cells and the GFP + cells, but not in the Fc R + /GFP + cells ( Fig. 6 B ) . This result is consistent with the previously reported antiapoptotic activity of FAIM3/TOSO ( Hitoshi et al., 1998 ) . It should be noted, however, that addition of control IgM of either human or mouse origin at a 100-fold molar excess into these cultures did not make the Fc R + /GFP + cells susceptible to IgM anti-Fas mAb-induced apoptosis, suggesting that the simultaneous dual binding to Fas and Fc R (i.e., cis interaction) is dominant over the single binding to Fc R (i.e., trans interaction) in this apoptosis model ( Fig. S4 ) . Unlike the eff ect seen with IgM anti-Fas mAb, ligation of Fas recep- 37°C (B) before cell lysis. Fc R was immunoprecipitated from cleared lysates with anti-Fc R (HM14) or control (Cont.) mAb-coupled beads, resolved on SDS-10% PAGE under reducing conditions, transferred onto membranes, and immunoblotted with rabbit antibody specifi c for phosphoserine of PKC substrates along with HRP-labeled goat anti-rabbit Ig antibody (anti-PKC P-Ser) or with HRP-labeled antiphosphotyrosine mAb (anti-P-Tyr) before visualization by ECL. After dissociating blotted antibodies, membranes were reprobed with biotin-labeled anti-Fc R mAbs along with HRP-labeled SA (anti-Fc R). These experiments were performed at least three times. M r is shown in kilodaltons.
CD11a were also unaff ected. We extended this analysis to the 697 pre-B cell line. Consistent with our previous IgM-binding results ( Ohno et al., 1990 ) , these cells do not constitutively express cell-surface Fc R, but its expression could be induced by PMA treatment ( Fig. S5 ) . After GPI-PLC treatment, the surface levels of Fc R and CD19 on PMA-activated 697 pre-B cells were unchanged, whereas the expression of GPI-anchored CD73 was reduced by ‫ف‬ 50% ( Fig. 7 B ) . Thus, these fi ndings indicate that Fc R is an authentic transmembrane protein, consistent with the predicted structure encoded by the Fc R cDNA.
To determine the M r of Fc R, we performed SDS-PAGE analysis of biotinylated cell-surface proteins that were precipitated from membrane lysates with anti-Fc R mAbs and IgM ligands. A major protein with an M r of ‫ف‬ 60 kD was precipitated from the Fc R-bearing but not control BW5147 T cells with both probes ( Fig. 7 C ) . The same M r estimate was obtained under both reducing and nonreducing conditions, indicating that there are no interchain disulfi de linkages of Fc R with itself or other proteins. Removal of sialic acid residues with neuraminidase from the ‫ف‬ 60-kD Fc R resulted in a decrease in M r to ‫ف‬ 50 kD. The cell-surface Fc R isolated from PMA-activated 697 pre-B cells and normal adult blood mononuclear cells (MNCs) had an identical M r of ‫ف‬ 60 kD, consistent with our previous size estimates ( Sanders et al., 1987 ; Ohno et al., 1990 ; Nakamura et al., 1993 ). An additional minor band of ‫ف‬ 40 kD was occasionally identifi ed in the precipitates from membrane lysates of Fc R + BW5147 T cells with anti-Fc R mAbs irrespective of detergents used (NP-40, digitonin, or CHAPS). The molecular identity of this 40-kD after transduction revealed that forced expression of Fc R resulted in down-modulation of their cell-surface IgM, presumably because of its ligation with the Fc R, thereby leading to loss of the Fc R + GFP + cell population. Thus, these findings suggest that the ectopic expression of Fc R on WEHI231 and Ramos B cell lines triggers BCR-mediated apoptosis as a consequence of direct interaction between the Fc R and membrane-bound IgM molecules.
Fc R is an ‫ف‬ 60-kD transmembrane protein Two hybridoma mAbs specifi c for human Fc R, HM7 ( ␥ 2b ), and HM14 ( ␥ 1 ) were established from mice immunized with Fc R + BW5147 T cells and were used along with the IgM ligand for biochemical characterization of the receptor. The HM7 mAb appeared to recognize an epitope near the IgM ligand binding site, because HM7 antibody binding was significantly inhibited by preincubation of Fc R + cells with IgM, whereas HM14 binding was not (unpublished data). Our earlier biochemical analysis revealed that Fc R on B-lineage cells could be attached to the plasma membrane via a glycosylphosphatidylinositol (GPI) linkage ( Ohno et al., 1990 ; Nakamura et al., 1993 ) , but the structure predicted by the cDNA is of a transmembrane protein. We thus reexamined this issue using a highly purifi ed GPI-specifi c phospholipase C (GPI-PLC). After GPI-PLC treatment, the surface expression of the GPI-anchored Thy-1 on Fc R + BW5147 T cells was reduced by ‫ف‬ 65%, whereas surface Fc R levels were unaff ected as determined by staining with both anti-Fc R mAbs and the IgM ligand ( Fig. 7 A ) . As expected, levels of the control transmembrane glycoprotein of staining with the HM14 mAb was higher than with the HM7 mAb (unpublished data), an observation consistent with the fi nding that the HM7 epitope is sensitive to IgM ligand binding; given its high affi nity, the Fc R is likely to be occupied by IgM in vivo. Clearly, mAb reactivity was a more sensitive assay for the detection of Fc R than ligand binding using biotin-labeled human IgM, although the sensitivity of the ligand-binding assay could be increased by using mouse IgM , biotin-labeled rat anti-mouse mAb and streptavidin (SA)-PE. In addition to B and T cells, CD56 + / CD3 Ϫ NK cells also expressed Fc R at relatively low density. Other blood cell types, CD14 + monocytes, CD13 + granulocytes, erythrocytes, and platelets, did not express Fc R at detectable levels ( Fig. S7 ) .
Notably, overnight culture of blood MNCs in IgM-free media enhanced Fc R expression especially by T cells ( Fig. 8 B ) , consistent with our previous IgM-binding data ( Nakamura et al., 1993 ) . Curiously, this enhancement was more evident for the cell preparations from the tonsils and spleen than from blood. Freshly isolated tonsillar MNCs, including B and T cells, had no reactivity with either anti-Fc R mAbs or IgM ligands, but after overnight culture, there was clear-cut expression of Fc R on the surface of the CD19 + B cells and the CD4 + and CD8 + T cells ( Fig. 8 C ) . Most follicular (IgD + / CD38 Ϫ ) and memory (IgD Ϫ /CD38 Ϫ ) B cells expressed Fc R, whereas only a small subpopulation of the germinal center (IgD Ϫ /CD38 + ) and pregerminal center (IgD + /CD38 + ) B cells expressed Fc R, consistent with our RT-PCR data. Many protein is presently unknown. Although the predicted pI of Fc R is ‫ف‬ 9.9, the ‫ف‬ 60-kD Fc R was resolved into a spot with a pI of ‫ف‬ 5 by two-dimensional gel electrophoresis analysis (unpublished data), consistent with our previous fi nding that Fc R is sialylated ( Ohno et al., 1990 ).
Fc R is predominantly expressed by both B and T lymphocytes To determine the cellular distribution of Fc R, we fi rst conducted RT-PCR analysis of various tissues and a panel of representative cell lines. Fc R transcripts were restricted to hematopoietic and lymphoid tissues, including the blood, bone marrow, tonsils, spleen, and appendix. Fc R transcripts were detected in both CD4 + and CD8 + T cells from blood as well as in all subsets of tonsillar B cells, although the transcript levels appeared highest in the follicular and memory B cells ( Fig. S6 , top) . Among the cell lines, 697 pre-B cells expressed Fc R transcripts, although they did not constitutively express cell-surface Fc R protein (Fig. S5) . Another pro-/pre-B cell line (REH) and some B cell lines (Ramos and the EVB-transformed line BDB-14.4) also contained Fc R mRNA (Fig. S6, bottom) .
Next, we examined cell-surface Fc R expression by immunofl uorescence analysis using receptor-specifi c mAbs and IgM ligands. In normal adult blood samples, Fc R was clearly expressed on CD19 + B cells and on the CD4 + and CD8 + T cells, although there was no discrete demarcation between Fc R + and Fc R Ϫ T cells ( Fig. 8 A ) . The intensity were incubated with PBS (blue) or 10 U/ml GPI-PLC (red) for 30 min at 30°C, and then examined for the expression of Fc R by anti-Fc R mAb or IgM ligand binding along with the expression of Thy-1 and CD11a (A) or of CD73 (ecto-5 Ј -nucleotidase) and CD19 (B). A control sample was kept on ice during this treatment without GPI-PLC (green). Note the signifi cant reduction in MFI of Thy-1 and CD73 but not of CD11a, CD19, Fc R, and IgM-binding profi les after GPI-PLC treatment. (C) SDS-PAGE analysis of cell-surface proteins. Plasma membrane proteins on control (BW) and Fc R-bearing BW5147 T cells (Fc R) were labeled with biotin, quenched, and incubated with mouse ␥ 1 control (Cont.) or anti-Fc R (HM14) mAbs or mouse IgM ligand before washing and solubilization in 1% NP-40 lysis buffer containing protease inhibitors. The mAb-bound cell-surface proteins were captured by addition of beads coupled with rat anti-mouse mAb (187.1 clone) and resolved on SDS-10% PAGE under nonreducing (not depicted) and reducing conditions, followed by transfer onto membranes, blotting with HRP-SA, and visualization by ECL. The same results were obtained with the HM7 anti-Fc R mAbs. The arrow indicates Fc R. The experiments were performed 3 times for A and B and >10 times for C.
To further examine the eff ects of cellular activation on surface Fc R expression, blood MNCs were activated with various stimuli. Treatments of blood B cells with anti-μ mAb or PMA for 24 h resulted in an ‫ف‬ 2.2-fold increase in the cell-surface Fc R level in comparison to that on B cells cultured in media only (unpublished data). In contrast, treatment of blood T cells with anti-CD3 mAb or PMA for 24-72 h reduced the cell-surface Fc R level by ‫ف‬ 90%, suggesting that signaling through antigen receptors on B and T cells has distinct modulating eff ects on Fc R expression. Consistent with previous observations ( Ferrarini et al., 1977 ; Pichler and Knapp, 1977 ; Sanders et al., 1987 ) , there was enhanced Fc R expression by CLL B cells from three randomly selected patient blood samples ( Fig. S8 ) . Collectively, these fi ndings indicate that, in striking contrast to other FcRs, Fc R is predominantly expressed by cells of the adaptive immune system. Moreover, the cell-surface levels of Fc R CD4 + T cells and the majority of CD8 + T cells clearly expressed cell-surface Fc R after culture. After overnight culture, the proportion of Fc R + B, CD4 + T, CD8 + T, and NK cells in the spleen was similar to that in blood samples (unpublished data). In adult bone marrow, a small subpopulation ( ‫ف‬ 21%) of the CD19 + /surface IgM Ϫ pro-/pre-B cells expressed low levels of Fc R on their cell surface, whereas ‫ف‬ 42% of the CD19 + /surface IgM + B cells expressed slightly higher levels of Fc R, indicating that Fc R expression begins at the pro-/pre-B cell stage in B-lineage diff erentiation ( Fig. 8 D ) . No Fc R expression was observed on myeloid cells even after overnight culture in IgM-free media. In contrast to the Fc R phenotype of humans, our initial immunofl uorescence analysis of mouse splenocytes with a receptorspecifi c mAb revealed that Fc R was expressed by B220 + B cells but not by CD3 + T cells or Mac-1 + macrophages (unpublished data). , tonsils (C), and bone marrow (D) were fi rst incubated with aggregated human IgG to block Fc ␥ Rs and then with biotin-labeled HM14 anti-Fc R mAb along with the appropriate fl uorochrome-labeled mAbs specifi c for CD19, IgM, IgD, CD38, CD3, CD4, CD8, or CD56. For IgM ligand binding, mouse IgM and biotin-labeled rat anti-mouse mAbs were sequentially added to MNCs without preincubation with aggregated IgG. The bound biotin-labeled reagents were detected by addition of SA-PE. Essentially the same results were obtained with the HM7 anti-Fc R mAb (not depicted). Because the results of the Fc R expression by CD3 + /CD8 + and CD3 + /CD4 Ϫ T cells were essentially the same, the CD8 data were omitted for simplicity. The cell populations indicated by the red boxes were gated and examined for their reactivity with the HM14 anti-Fc R mAb and IgM ligand. Biotin-labeled irrelevant mAbs of the ␥ 1 (for HM14) or ␥ 2b (for HM7) isotype were used as controls. The analysis was performed with freshly prepared cell preparations (A and D; labeled Fresh) or with cells cultured overnight in IgM-free media (O/N; B and C). Because the immunofl uorescence profi les of freshly prepared tonsillar B cells with anti-Fc R mAbs and isotype-matched control mAbs as well as these of overnight-cultured B cells with the isotype-matched control mAbs were all essentially the same, only the results of freshly prepared and overnight-cultured B cells with anti-Fc R mAbs are shown in C (top) for simplicity. CD19 + B cells in tonsils (C) were analyzed for Fc R expression as follicular/naive (IgD + /CD38 Ϫ ), pregerminal center (preGC; IgD + /CD38 + ), germinal center (GC; IgD Ϫ /CD38 + ), and memory (IgD Ϫ /CD38 Ϫ ) cells. The frequency (%) of Fc R + cells in each cell type among 10 different blood samples was 62 ± 18 for CD19 + B cells, 62 ± 13 for CD4 + T cells, 43 ± 23 for CD8 + T cells, and 19 ± 11 for CD56 + NK cells (means ± SD). The frequencies (%) of Fc R + cells over the background staining with isotype-matched control mAbs in three tonsillar samples were 31 ± 7 for follicular/naive, 15 ± 3 for preGC, 10 ± 3 for GC, and 30 ± 12 for memory B cells, and 34 ± 6 for CD4 + T and 51 ± 7 for CD8 + T cells (means ± SD). The experiments were performed >10 times for A and B, 3 times for C, and 2 times for D.
protein was unexpected, because in our previous biochemical analysis, the Fc R expressed on such pre-B cells was sensitive to GPI-PLC, whereas the Fc R on blood T cells was resistant ( Ohno et al., 1990 ; Nakamura et al., 1993 ). An intensive search for an alternatively spliced transcript encoding a GPI-linked form of Fc R was unsuccessful but led to identifi cation of an Fc R splice variant lacking the transmembrane exon that may encode a soluble form of Fc R with an M r of ‫ف‬ 34 kD (unpublished data). Reexamination of the susceptibility of Fc R to GPI-PLC treatment yielded an unequivocal result: the expression of Fc R on both PMAactivated 697 pre-B cells and T cell transductants was unchanged after GPI-PLC treatment, whereas the surface expression of GPI-anchored CD73 or Thy-1/CD90 was reduced by 50-65%. Thus, the discrepancy is likely caused by the fact that the GPI-PLC available for our studies in 1990 contained residual contaminating protease activity.
Unlike other FcRs, the Fc R has a relatively long cytoplasmic tail containing three conserved tyrosine and fi ve to nine conserved serine residues. We found that some of these tyrosine and serine residues are targets for phosphorylation after Fc R ligation with IgM immune complexes or pervanadate treatment. Intriguingly, the phosphorylated Fc R was found to migrate on SDS-PAGE faster than the unphosphorylated form. One possible explanation for this is that such phosphorylation may cause a global structural change of Fc R leading to increased mobility on SDS-PAGE. Although phosphorylated proteins usually migrate slower than their unphosphorylated forms, CD45 on a myeloid cell line in fact exhibits enhanced mobility on SDS-PAGE after PMAinduced phosphorylation ( Buzzi et al., 1992 ) . Another explanation may be proteolytic cleavage in the cytoplasmic tail of Fc R after receptor ligation, as has been observed in the Fc ␥ RIIA on platelets ( Gardiner et al., 2008 ) . Fc ␥ RIIA ligation on platelets leads to activation of both the metalloprotease that targets the collagen receptor GPVI to shed its ectodomain and the intracellular calpain that cleaves the cytoplasmic tail of Fc ␥ RIIA to remove the immunoreceptor tyrosine-based activation motif-containing stub, suggesting a novel mechanism for platelet dysfunction by Fc ␥ RIIA after immunological insult including IgG autoantibodies to platelets. The precise mechanism for the enhanced migration of phosphorylated Fc R awaits further investigation.
Nucleotide sequence analysis indicated that Fc R and FAIM3/TOSO are identical, but we have clearly shown that the antiapoptotic activity of Fc R in Fas-bearing Jurkat cells is only observed when agonistic anti-Fas mAb of an IgM but not IgG 3 isotype is used and that the Fc R expression itself does not prevent Fas-mediated apoptosis. Addition of a 100-fold molar excess of control IgM into these cultures did not convert the Fc R + GFP + cells from resistance to sensitivity to IgM anti-Fas mAb-induced apoptosis. Even when Fc R and Fas on Fc R + cells were brought into close physical proximity by ligation with a common secondary antibody, Fc R did not inhibit Fas-mediated apoptosis. Notably, Hitoshi et al. ( 1998 ) found that a FAIM3/TOSO deletion are sensitive to IgM ligand concentration, tissue milieu, and cellular activation status.
DISCUSSION
We have identifi ed for the fi rst time a bona fi de Fc R cDNA in humans. By using receptor-specifi c mAbs and IgM ligands, Fc R is defi ned as an ‫ف‬ 60-kD transmembrane sialoglycoprotein. Its predicted structure consists of a single V-set Ig-like domain with homology to the Ig-binding domains of pIgR and Fc ␣ /μR, an additional extracellular region with no known domain features, a transmembrane segment containing a charged His residue, and a relatively long cytoplasmic tail carrying conserved Tyr and Ser residues. Pentameric IgM and its Fc 5 μ fragments bound cell-surface Fc R on transductants, but the Fabμ fragments and other Ig isotypes did not, thereby confi rming the Fc specifi city of this receptor. The affi nity of the Fc R for its IgM ligand is strikingly high, ‫ف‬ 10 nM. Despite the initial designation of Fc R as an antiapoptotic protein FAIM3/TOSO, Fc R per se had no inhibitory activity in Fas-mediated apoptosis, and such inhibition was only achieved when agonistic anti-Fas antibody of an IgM but not IgG isotype was used for inducing apoptosis. The cell types expressing Fc R were predominantly B and T cells and not phagocytes; hence, the cellular distribution of Fc R is quite distinct from that of other FcRs. The surface Fc R levels on those lymphocytes were susceptible to IgM ligand concentration, tissue milieu. and cellular activation.
The FCMR gene is found to be in an appropriate location on chromosome 1q32.2 adjacent to two other IgMbinding receptor genes ( PIGR and FCAMR ). Although the ligand-binding domains of these three receptors are similar to each other, Fc R seems to be the most distantly related among the group based on the following fi ndings. (a) Many residues are well conserved in pIgR and Fc ␣ /μR but not in Fc R. (b) The length of the CDR1 region, which is predicted to contact the Ig ligands, is shorter in Fc R (5 aa) than in pIgR and Fc ␣ /μR (9 aa). (c) Within the CDR1 region, there are two charged residues: Arg31 conserved in both pIgR and Fc ␣ /μR, and His32 conserved in all three receptors. Although Arg31 is predicted to be solvent exposed and to interact directly with polymeric IgA ( Hamburger et al., 2004 ) , Fc Rs from seven diff erent species have a noncharged residue at the corresponding position. (d) Fc R recognizes only the IgM isotype, whereas both pIgR and Fc ␣ /μR in humans bind polymeric IgA and IgM ( Kaetzel, 2005 ; Kikuno et al., 2007 ) . These fi ndings thus suggest that the interaction of Fc R with its IgM ligand is distinct from that of pIgR and Fc ␣ /μR with IgM and polymeric IgA. In this regard, the fi nding that Fc 5 fragments mostly consisting of the C 3/ C 4 domains inhibit IgM binding to Fc R suggests that Fc R recognizes a molecular confi guration on IgM that is conferred by the C 3/C 4 domains. In contrast, pIgR recognizes the C-terminal domain C 4 ( Kaetzel, 2005 ) .
The fi nding that the Fc R cDNAs identifi ed in two cDNA libraries from PMA-activated 697 pre-B cells and CLL B cells encode a transmembrane but not a GPI-linked consistent with the results previously reported by others ( Pricop et al., 1993 ; Rabinowich et al., 1996 ) . The physiological relevance of such restricted cellular expression of Fc R may be related to unique features of the IgM ligand, such as its early appearance during immune responses, the pentameric confi guration of its secreted form, and its potency in complement activation.
Many investigators had previously noticed the instability of IgM binding by B, T, and NK cells ( Moretta et al., 1977 ; Nakamura et al., 1993 ; Pricop et al., 1993 ) . We also found that the cell-surface Fc R levels were sensitive to extracellular IgM concentration, tissue milieu, and cellular activation status. This vulnerability could explain why Fc R was limited to an operationally defi ned entity for such a long time.
As is the case with many other receptors, the detection of Fc R with IgM ligands was much less effi cient than with anti-Fc R mAbs. Short-term culture in IgM-free media enhanced the cell-surface expression of Fc R on T cells and, to a lesser extent, on B and NK cells. Remarkably, this phenomenon was much more pronounced with cells from tonsils and spleen; cell-surface Fc R was not detectable on freshly isolated B and T cells from these organs but easily demonstrated after overnight culture in IgM-free media. Many other cell-surface antigens were detectable in those freshly isolated preparations, ruling out an artifact of tissue manipulation. To our knowledge, the IgM concentration in the interstitial spaces of such intact tissues has never been determined. If this in vivo down-modulation of Fc R is solely dependent on the extracellular concentration of IgM and not on the tissue microenvironment (e.g., proteases) or cellular activation status, then the interstitial IgM concentration in secondary lymphoid tissues is perhaps higher than in blood. In this regard, it is noteworthy that IgM-producing plasma cells are in the immediate vicinity of B and T cells within these lymphoid tissues.
Although both B and T cells express Fc R, there is a striking diff erence in their response after antigen receptor ligation. Fc R expression on B cells was up-regulated after treatment with anti-μ mAb, whereas its expression on T cells was down-modulated after treatment with anti-CD3 mAb. The response to PMA was also diff erent in the B and T cells, suggesting that the difference might be attributed to the downstream events involving PKC. The role of PKC in internalization of cell-surface receptors including TCR has been clearly demonstrated ( Cantrell et al., 1985 ; Minami et al., 1987 ; Bonefeld et al., 2003 ) . PKC is a conserved family of 11 serine/threonine protein kinases, and most cell types express multiple isozymes of PKC ( Spitaler and Cantrell, 2004 ) . PKC ␣ , ␤ , ␦ , , , , and are known to be present in lymphocytes. Interestingly, the disruption of the gene encoding a single PKC isozyme expressed in both B and T cells (e.g., PKC ␤ Ϫ / Ϫ , PKC Ϫ / Ϫ , and PKC ␦ Ϫ / Ϫ ) often caused a selective immunological abnormality in only one of the cell types, suggesting compensatory or complementary functions of other PKC isozymes in the other cell type ( Spitaler and Cantrell, 2004 ) . Based on the consensus sequence motifs, there are several potential Ser residues available for phosphorylation by PKC in mutant lacking most of its cytoplasmic tail could still inhibit apoptosis mediated by IgM anti-Fas mAb, implying that FAIM3/TOSO might act indirectly through noncovalent association with another cell-surface protein. This might be relevant to our fi nding that an additional membrane protein of ‫ف‬ 40 kD often coprecipitated with the ‫ف‬ 60-kD Fc R from membrane lysates of Fc R + cells and that there is a charged His residue, which could be involved in electrostatic association with other proteins, adjacent to the transmembrane segment of Fc R. We therefore propose that the original designation of this gene as FAIM3/TOSO should be reconsidered and that renaming it FCMR would be more appropriate in keeping with its true physiological role.
Another reason to rename this gene is that several groups ( Pallasch et al., 2008 ; Proto-Siqueira et al., 2008 ) have recently reported that FAIM3/TOSO is overexpressed in CLL, a heterogeneous leukemia thought to originate from antigen-stimulated B cells that escape normal cell-death mechanisms. The interpretation of this fi nding by both groups is that the resistance of CLL B cells to death mechanisms may result from the enhanced expression of "antiapoptotic" FAIM3/ TOSO molecules. However, enhanced Fc R expression by CLL B cells had been consistently observed by many investigators using either rosetting or immunofl uorescence methods ( Ferrarini et al., 1977 ; Pichler and Knapp, 1977 ; Sanders et al., 1987 ) . Although the mechanism for enhanced Fc R expression on CLL cells is unclear, it may result from chronic antigenic stimulation as supported by (a) reduced levels of membrane IgM, IgD, and CD79/Ig ␣ /Ig ␤ on CLL cells and (b) polyreactivity of CLL-derived IgM molecules ( Chiorazzi et al., 2005 ) . In this regard, our fi nding that treatment of normal blood B cells with anti-antibody down-modulates membrane IgM and up-regulates Fc R cell-surface expression is consistent with the hypothesis that CLL cells are being activated by certain common antigens; thereby, antigen-driven proliferation may provide an alternative mode of survival of the leukemic cells.
The fi nding that the major cell types expressing Fc R are the adaptive immune cells, both B and T lymphocytes, is remarkable, because FcRs for the switched Ig isotypes (Fc ␥ Rs, Fc RI, and Fc ␣ R) are expressed by various hematopoietic cells, including phagocytes, and are thought to be central mediators coupling the innate and adaptive immune responses . Intriguingly, Fc R is the only FcR constitutively expressed on T cells, which are generally negative for the expression of other FcRs. The expression of Fc R by both CD4 + and CD8 + T cells is consistent with an early report that T cells forming rosettes with IgMcoated erythrocytes included both cell types ( Reinherz et al., 1980 ) . For B cells, Fc R is the only IgM-binding receptor expressed. Although the initial report indicated that Fc ␣ /μR is expressed on B cells ( Shibuya et al., 2000 ) , our subsequent analyses revealed that the major cell type expressing Fc ␣ /μR was a follicular dendritic cell in both humans ( Kikuno et al., 2007 ) and mice (unpublished data) . A small subpopulation of blood CD56 + /CD3 Ϫ NK cells was also found to express Fc R, Transfection, transduction, and screening. The cDNA libraries were transfected into the ecotropic retroviral packaging cell line BOSC23 with FuGENE 6 (Roche). 2 d later, the culture supernatants containing viruses were collected and fi ltered, and polybrene (Sigma-Aldrich) was added to a fi nal concentration of 10 μg/ml before infecting the mouse thymoma line BW5147 at a ratio of ‫ف‬ 3 × 10 5 cells/ml of supernatants. After 2 d, infected BW5147 T cells were incubated with biotin-labeled human IgM and then with antibiotin microbeads (Miltenyi Biotec) or PE-labeled SA (SouthernBiotech) before sorting IgM-binding cells by MACS or FACS, respectively. Enrichment of IgM-binding cells was repeated three times for MACS and once for FACS within the interval of ‫ف‬ 3 d, and the fi nal FACS-sorted cells were cloned by limiting dilution.
Identifi cation of cDNA inserts and sequencing. Total RNA isolated from single-cell derived, IgM-binding and -nonbinding subclones was converted to fi rst-strand cDNA with a primer (5 Ј -CCCTTTTTCTGGAGAC-TAAAT-3 Ј ) corresponding to the 3 Ј vector sequence fl anking the cloning site and SuperScript II RT (Invitrogen). The resultant fi rst-strand cDNAs were used as template DNAs in PCR amplifi cation with PrimeSTAR HS DNA polymerase (Takara Bio Inc.) and a set of primers corresponding to the 5 Ј and 3 Ј fl anking vector sequences of the cloning site, as previously described ( Arase et al., 2001 ) . Amplifi ed PCR products were subcloned into the ZeroBlunt TOPO vector (Invitrogen) before sequencing analysis was performed at our institutional sequencing core facility using a DNA analyzer (model 3730xl) and DNA Sequencing Analysis Software (version 5.2; both from Applied Biosystems).
Preparation of Fc R stable transductants. Total RNAs isolated from PMA-activated 697 pre-B cells, CLL B cells, and tonsils were similarly converted to fi rst-strand cDNA with an oligo(dT) 18 primer, and the resultant fi rst-strand cDNAs were used as template DNAs for amplifi cation of Fc R cDNA with a set of primers (forward, 5 Ј -AGATCT AGAAGGGACAATG-GACT-3 Ј , and reverse, 5 Ј -GAATTC TCAGGCAGGAACATTGATGT-3 Ј ; underlined portions indicate Bgl II and Eco RI sites). Amplifi ed products of the expected size of ‫ف‬ 1.2 kb were subcloned into the Bam HI and Eco RI sites of the pMXsPIE retroviral vector that contains a GFP cDNA and Streptomyces alboniger puromycin-N -acetyltransferase cDNA (a gift of A. Mui; DNAX, San Francisco, CA; Ehrhardt et al., 1999 ) . After confi rming sequence identity, the ligated Fc R cDNA construct and the empty vector were similarly transduced in BW5147 T cells, and the GFP + cells in both transductants were enriched by FACS and in the presence of 1 μg/ml puromycin. For Fc R + Jurkat cells, both the Fc R/GFP and GFP-only constructs were transfected into the 293T-A amphotropic packaging cell line before transducing the human Jurkat T cell line. GFP + cells were enriched three times by FACS before establishing the stable cell lines. In some experiments, both Fc R/GFP and GFP constructs were similarly transfected into an appropriate packaging cell line and transduced into WEHI231 mouse B cells and Ramos human B cells.
Ig ligands and binding assay. Human IgM myeloma proteins were purifi ed from serum samples by euglobulin fractionation and Sephacryl S-300 gel fi ltration column chromatography (GE Healthcare; Ohno et al., 1990 ) . The Fc 5 and Fab fragments were prepared from a human IgM by hot trypsin digestion ( Plaut and Tomasi, 1970 ; Ohno et al., 1990 ; Nakamura et al., 1993 ) . Other human myeloma Igs of each isotype ( ␥ 1, ␥ 2, ␥ 3, ␥ 4, ␣ 1, ␣ 2, ␦ , and ) and mouse myeloma IgM were purchased from EMD and SigmaAldrich. The purity of IgM, its fragments, and other myeloma Igs was confi rmed by SDS-PAGE under both reducing and nonreducing conditions. Protein concentration was determined by absorbance at 280 nm with an extinction coeffi cient of 1.4 as 1 mg/ml. For the binding inhibition assay, Fc R + BW5147 T cells were incubated with various concentrations of Ig preparations along with a constant amount of biotin-labeled IgM , washed, and incubated with PE-labeled SA to determine the bound IgM.
Production of hybridoma mAbs. BALB/c mice were hyperimmunized subcutaneously with BW5147 T cells expressing human Fc R, and regional lymph node cells were fused with the Ag8.653 plasmacytoma line, as previously the human Fc R, particularly R-R-K-A-L-S283-R-R or A-P-S359-L-K. Thus, it seems possible that Fc R expressed on B and T cells may have distinct infl uences on their respective antigen receptor-mediated signaling.
With regard to the function of Fc R on B cells, it has been shown that passive administration of IgM antibody, in contrast to IgG, enhances the subsequent antibody response to relevant antigenic challenge ( Hjelm et al., 2006 ) . Recent studies with mice unable to produce the soluble form of IgM have clearly demonstrated the importance of secreted IgM in development of protective IgG antibody responses to viral and bacterial infections, presumably through both complement and Fc R systems ( Boes et al., 1998a ; Boes et al., 1998b ; Ehrenstein et al., 1998 ; Ochsenbein et al., 1999 ; Baumgarth et al., 2000 ) . The complement cleavage products C3dg and C3d attach covalently to antigen and cross-link both CD21 (CR2) and BCR on the membrane of B cells, thereby facilitating the B cell response to low concentrations of antigen despite the typically low affi nity of BCR during the primary immune response ( Fearon and Carter, 1995 ; Fearon and Carroll, 2000 ) . The enhancing or adjuvant activity of C3d has been demonstrated with various antigens, although recently the inhibitory activity of C3d has also been reported for certain antigens ( Bergmann-Leitner et al., 2006 ) . Given that IgM antibody is a fi rst line of host defense, it is reasonable to propose that Fc R may contribute to enhancement of B cell responses by interacting with BCR and CD21/CD19/CD81 via IgM-antigen-C3d complexes. Another potential role for Fc R on B cells is antigen presentation. The functional signifi cance of Fc R on T cells has been the subject of considerable speculation ( Moretta et al., 1977 ; Mathur et al., 1988b ; Nakamura et al., 1993 ) . It seems possible that Fc R on T cells may interact with the IgM BCR or IgM/antigen complexes on B cells to facilitate T and B cell interactions, thereby enhancing B cell activation. Fc R may also trigger cytotoxic T cells in IgM antibody-dependent cell-mediated cytotoxicity. The true physiological roles of Fc R, however, will become apparent with further studies, including analysis of the immunological phenotypes in Fc R-deficient mice. Although the molecular nature of the Fc R has long been elusive, its fi nal unveiling in this study reveals a receptor full of intriguing aspects and opens new avenues of investigation.
MATERIALS AND METHODS
Construction of retroviral cDNA libraries. The cDNA libraries were constructed by a cDNA synthesis kit (Agilent Technologies) using poly(A) + RNA isolated by an Oligotex mRNA purifi cation kit (QIAGEN) from (a) blood MNCs from a patient with CLL and (b) the 697 pre-B cell line preactivated with 10 nM PMA for 8 h, as previously described ( Kubagawa et al., 1997 ) . The Eco RI/ Xho I-digested and size-fractionated cDNAs were ligated into the pMXsΔN/S retrovirus vector, in which the 1,328-bp Not I/ Sal I fragment containing an IRES and a GFP cDNA was removed from the original pMXsIG vector ( Kitamura et al., 2003 ) . The ligated cDNA constructs were used to transform XL2-Blue MRF Ј ultracompetent cells (Agilent Technologies). The titer of the cDNA library was ‫ف‬ 10 5 and ‫ف‬ 10 6 CFU/μg mRNA for CLL and 697 pre-B cells, respectively, and the mean size of the insert DNA in these libraries was ‫ف‬ 1.6 kb.
30 min before solubilizing in 200 μl of 1% NP-40 lysis buff er. The cleared lysates were subjected to immunoprecipitation with HM14 or AM3 mAbcoupled beads, and the bound materials were similarly analyzed by immunoblotting. Immunoblotted membranes were visualized by ECL. After dissociating the blotting antibodies, the membranes were reblotted with biotin-labeled antiFc R mAbs (HM14 and HM7) to confi rm the phosphorylation of Tyr and Ser residues of Fc R.
Apoptosis assay. 4 × 10 5 cells/ml were cultured for 24 h in RPMI 1640 containing 10% FCS, penicillin/streptomycin, and 5 × 10 Ϫ 5 M 2-ME in the presence or absence of either of the agonistic anti-Fas mAbs, CH11 (10 ng/ml; mouse μk isotype; Millipore) or 2R2 (300 ng/ml; mouse ␥ 3 ; Invitrogen), washed twice with PBS, and incubated with 7-AAD and allophycocyanin (APC)-labeled annexin V for detecting apoptotic cells according to the manufacturer's recommendation (BD). In some experiments, 100-fold molar excess of human or mouse IgM myeloma protein as a ligand was added in these cultures. In other experiments, cells were preincubated with the 2R2 antiFas mAb (300 ng/ml) and either F(ab Ј ) 2 fragments or the intact form of the HM14 anti-Fc R mAb (50 μg/ml) for 20 min at 4°C, washed, and cultured in the presence or absence of F(ab Ј ) 2 fragments of goat anti-mouse antibodies (50 μg/ml) overnight at 37°C.
Scatchard plot analysis. 2 × 10 6 Fc R + BW5147 T cells were incubated in triplicate with serial dilutions of 125 I-labeled IgM with a specifi c activity of ‫ف‬ 1.6 × 10 17 cpm/mol in 30 μl PBS containing 3% FCS and 0.2% sodium azide for 1.5 h at room temperature before washing and aspirating unbound IgM by centrifugation. Some tubes contained a 200-fold molar excess of cold IgM to determine the amounts of nonspecifi c binding of 125 I-labeled IgM to cells. The numbers of IgM molecules specifi cally bound per cell were plotted on the x axis against the ratio of bound to free IgM on the y axis, and the apparent dissociation constant was obtained by dividing the number of receptors per cell by the bound/free ratio at the y-axis intercept, as previously described ( Lowenthal et al., 2001 ).
Online supplemental material. Fig. S1 shows the nucleotide sequence of the human Fc R cDNA. Fig. S2 shows the defi nition of FAIM3/TOSO as an Fc R. Fig. S3 shows the predicted protein structure of human Fc R. Fig. S4 shows the eff ects of Fc R ligation on anti-Fas antibody-mediated apoptosis in Jurkat T cells. Fig. S5 shows the expression of cell-surface Fc R on 697 pre-B cell line before and after PMA stimulation. Fig. S6 shows FCMR gene expression analyzed by RT-PCR. Fig. S7 shows the lack of Fc R expression by monocytes, granulocytes, erythrocytes, and platelets. Fig. S8 shows enhanced Fc R expression on CLL cells. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20091107/DC1.
